Search: WFRF:(Knapp S) > (2005-2009) > Endogenous sex horm...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03363naa a2200373 4500 | |
001 | oai:DiVA.org:uu-16111 | |
003 | SwePub | |
008 | 080423s2006 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-161112 URI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Ärnlöv, Johanu Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)johaarnl |
245 | 1 0 | a Endogenous sex hormones and cardiovascular disease incidence in men |
264 | 1 | c 2006 |
338 | a print2 rdacarrier | |
520 | a Background: Data suggest that endogenous sex hormones (testosterone, dehydroepiandrosterone sulfate [DHEA-S], and estradiol) influence cardiovascular disease (CVD) risk factors and vascular function. Yet, prospective studies relating sex hormones to CVD incidence in men have yielded inconsistent results. Objective: To examine the association of circulating sex hormone levels and CVD risk in men. Design: Prospective cohort study. Setting: Community-based study in Framingham, Massachusetts. Participants: 2084 middle-aged white men without CVD at baseline. Measurements: The authors used multivariable Cox regression to relate baseline levels of testosterone, DHEA-S, and estradiol to the incidence of CVD (coronary, cerebrovascular, or peripheral vascular disease or heart failure) during 10 years of follow-up. Results: During follow-up, 386 men (18.5%) experienced a first CVD event. After adjustment for baseline standard CVD risk factors, higher estradiol level was associated with lower risk for CVD (hazard ratio per SD increment in log estradiol, 0.90 [95% Cl, 0.82 to 0.99]; P = 0.035). The authors observed effect modification by age: Higher estradiol levels were associated with lower CVD risk in older (median age > 56 years) men (hazard ratio per SD increment, 0.86 [Cl, 0.78 to 0.96]; P = 0.005) but not in younger (median age <= 56 years) men (hazard ratio per SD increment, 1.11 [Cl, 0.89 to 1.38]; P = 0.36). The association of higher estradiol level with lower CVD incidence remained robust in time-dependent Cox models (updating standard CVD risk factors during follow-up). Serum testosterone and DHEA-S levels were not statistically significantly associated with incident CVD. Limitations: Sex hormone levels were measured only at baseline, and the findings may not be generalizable to women and nonwhite people. Conclusions: In the community-based sample, a higher serum estradiol level was associated with lower risk for CVD events in older men. The findings are consistent with the hypothesis that endogenous estrogen has vasculoprotective influences in men. | |
653 | a MEDICINE | |
653 | a MEDICIN | |
700 | 1 | a Pencina, Michael J.4 aut |
700 | 1 | a Amin, Shreyasee4 aut |
700 | 1 | a Nam, Byung-Ho4 aut |
700 | 1 | a Benjamin, Emelia J.4 aut |
700 | 1 | a Murabito, Joanne M.4 aut |
700 | 1 | a Wang, Thomas J.4 aut |
700 | 1 | a Knapp, Philip E.4 aut |
700 | 1 | a D'Agostino, Ralph B.4 aut |
700 | 1 | a Bhasin, Shalendar4 aut |
700 | 1 | a Vasan, Ramachandran S.4 aut |
710 | 2 | a Uppsala universitetb Geriatrik4 org |
773 | 0 | t Annals of Internal Medicineg 145:3, s. 176-184q 145:3<176-184x 0003-4819x 1539-3704 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-16111 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.